Celon Pharma S.A announced it has signed a non-binding term sheet of 2,700,000 shares at issue price PLN 15 per share for gross proceeds PLN 40,500,000 on May 22, 2024. The transaction includes participation from new investor, Tang Capital Management, LLC.